Send to

Choose Destination
Cancer Invest. 1995;13(3):267-71.

Inflammatory breast cancer: 10-year follow-up of a trial of surgery, chemotherapy, and allogeneic tumor cell/BCG immunotherapy.

Author information

Los Angeles Oncologic Institute, St. Vincent Medical Center, California, USA.


A 10-year follow-up analysis has been performed on the cohort of 13 previously reported inflammatory breast cancer patients treated with chemotherapy, surgery, and allogeneic tumor cell/BCG vaccine. Follow-up of this duration is uncommon in the literature. Data indicate an apparent plateau of the survival curve at about 5 years, with 4 of 13 patients (31%) still alive after 10 years. Also noted is a long-term survival of an off-protocol patient with metastatic breast cancer treated with chemotherapy and vaccine. Although the role of vaccine cannot be directly determined from this study, this trial did demonstrate that long-term survival is a feasible goal for a significant fraction of patients with inflammatory breast cancer.

[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center